Chagas disease is a primary public health issue in Latin America. The World Health Organization (WHO) states that approximately eight million persons are infected in Latin America and an additional 20 million people are at risk of contracting the infection ([@B22]).

The first methods that were used to identify Chagas disease included the complement fixation test, which was used by Guerrero and Machado in 1913, as well as the identification of unilateral conjunctivitis and Romana's sign ([@B27], [@B28], [@B22]).

Historically, the possibility of transmission *via* blood transfusion was first described by [@B21], followed nine years later by [@B9] in Brazil and by [@B2] in Argentina. [@B30] in Uruguay reported a related study.

Reactive blood donors were diagnosed for the first time in 1949 using the complement fixation test in Belo Horizonte ([@B29]) and São Paulo, Brazil ([@B10], [@B13]).

Treatment of potentially infected donor blood using crystal violet dye was proposed at approximately the same time ([@B25]).

The risk of transmission of Chagas disease *via* blood transfusion is largely due to the following factors: (i) hundreds of donors are infected, but asymptomatic and the stage or phase of the disease is not known, (ii) donors come from geographical areas in which Chagas disease is endemic ([@B16]), (iii) serum-reactive donors are not detected at blood banks, (iv) symptoms of the disease in its chronic phase are mistaken for less severe pathologies, (v) no serological analyses are performed in urban areas or the analyses lack the appropriate sensitivity and specificity, (vi) transmission can occur by other routes, such as organ transplants, bone marrow transplants, accidents in the clinical laboratory and orally, (vii) congenital transmission, (viii) frequent immigration of persons from endemic zones to regions where the vector insect is not present and (ix) lack of vector control strategies, adequate epidemiological data and awareness of Chagas disease as a public health issue ([@B7]).

Control measures have been implemented during the last 20 years in Latin America, with a resulting drop in the prevalence of transmission by blood transfusions ([@B7]).

During the acute phase of the disease, antibody identification is possible by the fourth week after infection. The minimum standard for establishing an acute phase diagnosis is the documentation of serum conversion (from negative to positive) by conventional serological testing of two paired serum samples obtained less than one month apart. Parasitaemias are transitory during the chronic phase and parasite detection in blood is completely random with low sensitivity. The diagnosis is based on a finding of anti-*Trypanosoma cruzi*antibodies in the bloodstream ([@B19]).

Conventional serological tests alone are not sufficient, mainly because antigenic preparations are derived from parasite extracts or semi-purified fractions of epimastigotes (the non-infectious form of the parasite) and procedures differ between laboratories. Therefore, inconclusive results are frequently obtained ([@B3]). However, some patients with Chagas disease have false negative results ([@B17], [@B1]. The WHO recommends the use of three assays because of the aforementioned inconveniences and variations in the sensitivity of serological screening in blood banks and individual diagnoses. ELISA, indirect haemagglutination assays (IHA) and recombinant (rELISA) or indirect immunofluorescence assays (IFA) are used for the diagnosis of Chagas disease ([@B24], [@B12]. An infected person with reactive serum must undergo at least two serological assays ([@B12].

This practice is mandatory in Argentina and enforcement began in Brazil in December 2002. [@B23] demonstrated that the IHA technique has a very low sensitivity and is not a reliable test in blood donors. ELISA is therefore recommended for screening samples at blood banks; however, an ELISA test that employs recombinant antigens or synthetic peptides ([@B18]) and demonstrates high sensitivity and specificity should be used ([@B26], [@B27]).

Similarly, an epidemiological profile for the studied communities must be designed to evaluate variables in the population under study, such as housing type, co-habitation with animals, trips outside the communities of origin, symptomatology during the survey, age and age distribution and gender ([@B27]). This information will render an accurate profile of the rural localisation of this endemic disease, which is crucial for Mexico ([@B15]).

SUBJECTS, MATERIALS AND METHODS
===============================

*Population studied* - A total of 1,033 blood samples were drawn from subjects from 51 rural communities in 12 of the 18 municipalities in the state of Querétaro. Sampling was based on reports of an existing vector ([@B31]), housing conditions, co-habitation with animals and seropositivity (as reported by blood bank-based ELISA testing) ([@B8]).

The sample size was calculated using the statistical program Epi Info v.2002. Statistical analyses of frequencies and statistical significance were performed using SPSS 11.5 software.

The Committee of Bioethics and Research of the University of Granada, Spain approved this study.

*Blood sampling* - Blood samples were drawn during the epidemiological interview from the cubital vein of either the right or left forearm after the area was disinfected and cleaned using a cotton pellet soaked with a mixture of 5% glycerol in ethanol. Blood samples were collected in glass vacuum containers (7 mL) containing gel that inhibited blood clotting and prevented haemolysis. This precaution was important because samples were frequently moved during transportation to the laboratory. Blood was centrifuged at 5,000 rpm for 10 min to separate serum from the globular fraction. Serum was stored in five 50-µL aliquots and frozen at -20ºC until used.

*Serological assays* - Determination of antibody expression in the 1,033 serum samples was performed using conventional assays. Total extracts of the epimastigote forms of *T. cruzi* (BioMérieux^®^) were used for ELISA testing and cut-off points were established for each series of sera studied ([@B19]). rELISA (Wiener lab^®^) employed six antigens synthesised from trypomastigote and epimastigote fragments from various *T. cruzi*strains (SAPA, 1, 2, 13, 30 and 36) ([@B18]). Reactivity at dilutions \> 1:8 was considered positive for IHA (Wiener lab^®^). The Camargo method was employed for IFA, using complete forms of *T. cruzi* epimastigotes isolated from strain Y (of Brazilian origin) and strain T3 (of Mexican origin, state of Veracruz, derived from in vitro cultures in Grace medium). Samples with titres \> 1:16 were considered positive ([@B5], [@B3].

*New diagnostic techniques* - The iron superoxide dismutase (FeSOD) method uses the isoenzyme FeSOD as an immunogenic protein for *T. cruzi.*This protein is extracted from the epimastigote and trypomastigote forms, which were isolated from the Colombian strain and cultured in vitro in Grace medium (Sigma^®^) supplemented with 10% bovine foetal serum (v/v) (Gibco^®^) that had been previously heat inactivated at 56ºC for 30 min. Flagellates were cultivated in 3 mL of medium in 25-cm^2^ plastic Roux flasks (Corning) at 28ºC at an initial concentration of 5 x 10^4^cells/mL. Cultures were centrifuged at 1,500 rpm for 10 min when the cellular concentration reached approximately 2 x 10^7^ cells/mL (counted in a Neubauer haemocytometer chamber). The resulting pellet was rinsed twice in phosphate-buffered saline and centrifuged. The extracted enzyme was purified, fractioned and used as an antigen in Western blots to detect anti-*T. cruzi* antibodies in the 1,033 serum samples. The test was considered to be positive when anti-*T. cruzi* antibodies were detected at a dilution of 1:80 ([@B20], [@B3]. Evaluations of statistically significant differences between the tests were based on sensitivity, specificity, negative and positive predictive values, concordance percentage and the kappa index. The following epidemiological variables were considered in this study: presence of the vectors*Triatoma mexicana*(94%), *Triatoma dimidiate*(3%), *Triatoma gerstaeckeri*(2%) and *Triatoma pallidipennis*(1%) ([@B33], gender, age, housing type, co-habitation with animals, trips outside the community and reported symptomatology that was compatible with known signs and symptoms of the acute or chronic phases of Chagas disease. Comparisons between epidemiologic parameters and survival patterns were established in every studied population ([@B11]. Statistical analyses were performed using SPSS v.11.5 to measure confidence values and statistical significance between parameters.

These data were collected using an epidemiological survey, which was completed at the time of blood sample collection.

RESULTS AND DISCUSSION
======================

The five immunological tests were performed in 1,033 samples and yielded the following percentages of positive findings: ELISA 8%, rELISA 6.2% and IHA and IFA 5.4%. The 8% positive rate for FeSOD testing was consistent with the results of the most commonly used antibody test ([Fig. 1](#f01){ref-type="fig"}, [Table I](#t01){ref-type="table"}).

Fig. 1: immunological tests applied to samples of the studied individuals in rural communities in the state of Querétaro, Mexico. FeSOD: iron superoxide dismutase; IFA: indirect immunofluorescence assay; IHA: indirect haemagglutination assay; rELISA: recombinant ELISA.

TABLE ISeroreactive tests at *Trypanosoma cruzi*in population of different communities of the state of Querétaro, MéxicoMunicipalitiesRural communitiesSeroreactive (n)Seropositivity at two tests (n)Total persons sampled (n)ELISArELISAIHAIFAFeSODSantiago de QuerétaroRancho el Pitayo11111131Arroyo SecoTanchanaquito11001122El Rejalgar110011Pinal de AmolesLas Adjuntas20222260Barranca del Plátano211122El Plátano111111Landa de MatamorosLa Aguita3111333PeñamillerAlamitos32223387El Pilón423344CadereytaBoyecito853378218Llanitos743377TolimánPanales222222290San Pablo422244Horno de Cal212222ColónEl Gallo11911111111122Viborillas110011El MarquésSan Vicente Ferrer954499109Atongo223322Tierra Blanca210022HuimilpanGuadalupe 110001127Las taponas111111Santa Teresa111111San Juan del RíoSan Juan del Río9610109949CorregidoraAlfayúcan11111115Joaquín Herrera110011Total-8062545480801,033[^1]

All serological techniques are used primarily during the latent and chronic stages of infection, when it is difficult to identify the parasites. Cross-reactivity of Chagas disease tests with circulating antibodies related to other infections and diseases, such as leishmaniasis, malaria, toxoplasmosis, hepatitis, leprosy, syphilis and collagen vascular diseases, is common ([@B6], [@B4], [@B14]). This cross-reactivity inspired us to conduct a study of five different serologic tests to determine the statistical concordance among these tests and identify the true seroprevalence rate, as has been previously described by the WHO ([@B12]). The results are shown in [Table II](#t02){ref-type="table"}.

TABLE IIStatistical correlation between the five immunological tests used in the study with the enzyme Western blots-iron superoxide dismutase (FeSOD) match is 100%AssaysSensitivity (%)Specificity (%)PPV (%)NPV (%)Concordance (%)Kappa indexELISA r-ELISA75.699.998.598980.8ELISA-IFA68.299.998.397970.8ELISA-IHA63.510010097970.8ELISA-FeSOD94.410098.4981000.96[^2]

The statistical correlation rates between the five immunological tests were 8% between ELISA and FeSOD, 6.2% between ELISA and rELISA and 5.4% between IHA and ELISA-ELISA-IFA, showing that the sensitivity and specificity varied considerably. However, this variability can be attributed to technical problems. For example, recent recommendations suggest the use of fresh sera and avoiding freezing and thawing samples that will be used for rELISA because sensitivity with respect to IHA is lost. IHA does not work with antigenic extracts of *T. cruzi* strains that are obtained from humans; this test uses sensitised erythrocytes from sheep blood with antigenic extracts of the epimastigote forms of cultured *T. cruzi*, which reduces sensitivity and specificity. The predictive values and kappa index confirmed the usefulness of performing two immunological tests for the detection of possible infections with this haemoflagellate parasite.

Seroprevalence according to age showed that seropositivity decreases in increments as age increases. The survey also showed that infection is often present at a very young age, which implies the establishment of the vector in the risk zone ([Fig. 2](#f02){ref-type="fig"}).

Fig. 2: prevalence of *Trypanosoma cruzi* seropositivity according to age group. FeSOD: iron superoxide dismutase; IFA: indirect immunofluorescence assay; IHA: indirect haemagglutination assay; rELISA: recombinant ELISA.

A total of 8.8% of seroreactive inhabitants were of reproductive age and they performed various activities. Therefore, a socio-economic problem arises when these inhabitants become infected because they are part of the economic support of their families. Most of the subjects in this study were women (74%) and only 26% were men.

The majority of individuals sampled in this study (83.3%) were between the ages of 16-50 years old. This population often moves to other areas for work, study or leisure and they are considered high risk. Subjects between one-15 years of age made up 15.2% of the sample and subjects between 51-95 years old constituted 1.5% of the sample ([Fig. 3](#f03){ref-type="fig"}).

Fig. 3: percentages of age groups in the studied population.

Most of the population (99.3%) did not travel outside their communities and remained in the same locality for their entire lives. Additionally, the majority of the population (98%) cohabited with animals and 8.7% had symptoms of infection, according to the survey that was performed at the beginning of the study.

The type of housing played an important role in the epidemiology of the infection because building materials constitute an important variable in the establishment of the vector. Details regarding the housing type are summarised in [Table III](#t03){ref-type="table"}.

TABLE IIIPercentage of the types of material that forms part of ceilings, walls, fences and floors wthat are part of the construction of the houses of seropositive individuals studiedMaterialStraw (%)Sheet (%)Cardboard (%)Wood (%)Clay (%)Adobe (%)Ground (%)Concrete (%)Stone (%)Roof70707020\-\--10-Wall88-15151010\--90Ground50\-\-\-\--506050

The only statistically significant difference noted in this study was in the percentage of the different tests that were reactive, relative to symptomatology ([Fig. 4](#f04){ref-type="fig"}).

Fig. 4: percentage of reactive cases in the relation to the different assays. FeSOD: iron superoxide dismutase; IFA: indirect immunofluorescence assay; IHA: indirect haemagglutination assay; rELISA: recombinant ELISA.

The Official Mexican Norm ([@B24]) regarding blood testing for Chagas disease (NOM-033.SSA1-1997) mentions only that assays must be performed in cities in geographical areas where Chagas is endemic. The results obtained between ELISA-FeSOD was 8%, which indicates that infection by *T. cruzi* in Querétaro is five times higher than the national average of 1.6% ([@B15]). The 8% seropositivity rate means that 84 individuals are reactive. If this rate is extrapolated to the entire population, an estimated 40,000 persons are infected, 30% of whom will develop cardiac disease in the next 15-20 years. It is important to mention that Querétaro should be considered an endemic area because our results reflect a high percentage of high-risk individuals and there is active transmission of infection (15.2% age paediatric). The results have been reported to the Health Services of the State of Querétaro. We were also able to establish ELISA as the test of choice for the detection of anti-*T. cruzi* antibodies for all persons who donate blood at the State Centre of Haemotherapy. Testing for *T. cruzi* should not be reserved for individuals from endemic areas, despite possible controversy.

Similarly, the results obtained with ELISA and FeSOD testing, which are sensitive and specific for genus and species, found that the use of an enzyme-extracted parasite as the antigen (instead of antigenic extracts of epimastigote forms and/or trypomastigotes) cross-reacted with other aetiological agents; this technique should therefore be avoided because of the risk of false positive findings.

New diagnostic techniques, such as the superoxide dismutase technique, have been designed as confirmatory tests to overcome this problem. The superoxide dismutase assay is the only diagnostic approach that can identify anti-*T. cruzi* antibodies ([@B32]). It should be used in blood banks as the only definitive diagnostic test for the detection and confirmation of reactive Chagas infection and can eliminate the need to perform second and third tests for the disease ([@B34], [@B33].

The collected data show active transmission of*T. cruzi* in Querétaro, which was not previously considered an endemic zone*.*
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[^1]: new diagnostic tool is considered, the iron superoxide dismutase (FeSOD). IFA: indirect immunofluorescence assay; IHA: indirect haemagglutination assay; rELISA: recombinant ELISA.

[^2]: IFA: indirect immunofluorescence assay; IHA: indirect haemagglutination assay; NPV: negative predictive values; PPV: positive predictive values; rELISA: recombinant ELISA.
